Cargando…
Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis
Background: N6-methyladenosine (m6A) is the most abundant epigenetic modification. Although the dysregulation of m6A regulators has been associated with cancer progression in several studies, its relationship with cancer prognosis and clinicopathology is still controversial. Therefore, we evaluated...
Autores principales: | Su, Zhangci, Xu, Leyao, Dai, Xinning, Zhu, Mengyao, Chen, Xiaodan, Li, Yuanyuan, Li, Jie, Ge, Ruihan, Cheng, Bin, Wang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699754/ https://www.ncbi.nlm.nih.gov/pubmed/36347025 http://dx.doi.org/10.18632/aging.204371 |
Ejemplares similares
-
The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2018) -
The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis
por: Qiu, Liping, et al.
Publicado: (2022) -
Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis
por: Zhang, Shuo, et al.
Publicado: (2020) -
Clinicopathological and prognostic significance of FoxM1 in hepatocellular carcinoma patients: a meta-analysis
por: Liang, Chaojie, et al.
Publicado: (2018) -
Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis
por: Qiao, Weiqiang, et al.
Publicado: (2017)